CAMBRIDGE, Mass.--(BUSINESS WIRE)--
February 21, 2012-- Metabolix, Inc. (NASDAQ:MBLX), a bioscience company
focused on bringing clean, sustainable solutions to the plastics,
chemicals and energy industries, announced today that it will be
releasing its fourth quarter and fiscal 2011 financial results after the
market close on Tuesday, March 6, 2012. The full text of the earnings
release will also be available on the Company's website at www.metabolix.com.
Richard Eno, the Company's President and CEO, Joseph Hill, CFO, and
Oliver Peoples, Co-founder and CSO, will host a conference call on the
same day at 4:30 p.m. (Eastern) to discuss the results of the fourth
quarter and fiscal year ended December 31, 2011. The Company will also
provide an update on the business and answer questions from the
investment community. To participate, dial toll-free 1-888-500-6970 or
1-719-325-2419 (international). The pass code is 2602945. The conference
call will also be webcast and can be accessed from the Company's website
at www.metabolix.com
in the investor relations section.
To listen to a telephonic replay of the conference call, dial toll-free
1-877-870-5176 or 1-858-384-5517 (international) and enter pass code
2602945. The replay will be available beginning at 7:30 p.m. (Eastern)
on Tuesday, March 6, 2012 and will last through 11:59 PM (Eastern) March
20, 2012. In addition, the webcast will be archived on the Company's
website in the investor relations section.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation-driven bioscience
company focused on providing sustainable solutions for the world's needs
for plastics, chemicals and energy. The Company is taking a systems
approach, from gene to end product, integrating sophisticated
biotechnology with advanced industrial practice. Metabolix is developing
biosourced industrial chemicals and plastics, as well as a proprietary
platform technology for co-producing plastics, chemicals and energy,
from crops such as switchgrass, oilseeds and sugarcane.
For more information, please visit www.metabolix.com.
(MBLX-E)
Metabolix General Inquiries:
Lynne H. Brum, 617-682-4693
LBrum@metabolix.com
or
Investor
Relations:
ICR
James R. Palczynski, 203-682-8229
james.palczynski@icrinc.com
Source: Metabolix, Inc.
News Provided by Acquire Media
